Midissia Therapeutics

KEI and UACT comments on the prospective grant of an exclusive license to Midissia Therapeutics

Posted on by KEI Staff

Below are the comments filed by Knowledge Ecology International (KEI) and the Union for Affordable Cancer Treatment (UACT) regarding a prospective grant of an exclusive license of NIH-owned patents to the California-based company Midissia Therapeutics. The prospective exclusive license is… Continue Reading →

2016: Midissia Therapeutics license of NIH owned breast and prostate cancer vaccine patents

Posted on by KEI Staff

(More on government funded inventions here. Other KEI comments on NIH licenses are found here.) Sabarni K. Chatterjee, Ph.D., M.B.A. Senior Licensing and Patenting Manager, NCI Technology Transfer Center, 9609 Medical Center Drive, RM 1E530 MSC 9702, Bethesda, MD 20892-9702… Continue Reading →